Google AI


The Times

.

Bora Pharmaceuticals 2Q25 Operating Margin Expanded 5 Percentage Points, Reaching Quarterly High Since The Start of Integration in 4Q24; Strong Momentum Poised to Accelerate in 2H25 As Operational Efficiency Gains Materialize

HONG KONG SAR - Media OutReach Newswire - 8 August 2025 - Bora Pharmaceuticals (TWSE: 6472) today announced its financial results and operational highlights for second quarter of 2025.

Quarterly Business and Financial Highlights

· Company reported quarterly basic EPS of NT$5.95, with NT$1.81 from discontinued operations.

More Articles …

  1. HK-listed IVD Medical Invests HK$149M in Ethereum through HashKey Exchange
  2. Jurassic World: The Experience, A New Immersive Walk-Through Experience Opens In Bangkok At Asiatique The Riverfront Destination
  3. Asian Firms Divided on Insolvency Outlook Amid Ongoing Trade Challenges
  4. Energea reveals modernized travel tech collection with elevated design details
  5. Schneider Electric reports significant sustainability milestones in Q2 2025
  6. Henkel celebrates 50 years of innovation, sustainability and trusted partnerships in Australia
  7. Doctor-patient trust is key to unlocking AI's potential to improve healthcare in Australia, finds Philips' Future Health Index Report
  8. Worldgate’s VSING Partners with GENDA to Tap into Japanese Market, to Create Interactive Live-streaming Karaoke Experience
  9. Pfizer Romania recognized as a Best Place to Work for 2025
  10. Amari Vientiane, Laos, Honoured with Four Prestigious Awards at the Haute Grandeur Global Awards 2025